Menlo Therapeutics Inc. Contracts & Agreements

82 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to License Agreement (Topical) between Tay Therapeutics Ltd and VYNE Therapeutics Inc.
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2025
First Amendment to VYNE Therapeutics Inc. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2024
Sales Agreement between VYNE Therapeutics Inc. and Cowen and Company, LLC for Up to $50 Million of Common Stock
Sales Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2024
VYNE Therapeutics Inc. Non-Employee Director Compensation Policy (Effective December 11, 2023)
Compensation Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2024
VYNE Therapeutics Inc. 2023 Equity Incentive Plan
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2023
VYNE Therapeutics Inc. 2023 Equity Incentive Plan Share Option Grant Notice and Agreement for US Director
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2023
VYNE Therapeutics Inc. Share Option Grant Notice and Option Agreement (2023 Equity Incentive Plan)
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2023
VYNE Therapeutics Inc. 2023 Equity Incentive Plan Restricted Share Unit Award Agreement
Compensation Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2023
VYNE Therapeutics Inc. Pre-Funded Warrant to Purchase Common Stock Agreement
Warrant Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2023
Securities Purchase Agreement between VYNE Therapeutics Inc. and Purchasers (October 27, 2023)
Purchase Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2023
Registration Rights Agreement between VYNE Therapeutics Inc. and Purchasers Dated October 27, 2023
Registration Rights Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2023
Exclusive License Agreement (Oral) between Tay Therapeutics Limited and VYNE Therapeutics Inc. – Oral BETi Compounds
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2023
Letter Agreement Extending Option Term and Evaluation Rights Between VYNE Therapeutics Inc. and Tay Therapeutics Limited (Feb. 27, 2023)
Menlo Therapeutics Inc.
Pharmaceuticals
2023
Description of Registered Securities of VYNE Therapeutics Inc. under Section 12 of the Exchange Act
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2023
Securities Purchase Agreement between VYNE Therapeutics Inc. and Purchaser (November 11, 2022)
Purchase Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2022
Registration Rights Agreement between VYNE Therapeutics Inc. and Purchaser (November 11, 2022)
Registration Rights Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2022
Description of Registered Securities of VYNE Therapeutics Inc. under Section 12 of the Exchange Act
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2022
Purchase Agreement between VYNE Therapeutics, Inc. and Lincoln Park Capital Fund, LLC dated March 15, 2022
Purchase Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2022
Registration Rights Agreement between VYNE Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (March 15, 2022)
Registration Rights Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2022
Asset Purchase Agreement between VYNE Therapeutics Inc. and Journey Medical Corporation dated January 12, 2022
Purchase Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2022
License Agreement (Topical) between In4Derm Limited and VYNE Therapeutics Inc. dated August 9, 2021
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021
Evaluation and Option Agreement between In4Derm Limited and VYNE Therapeutics Inc.
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2021
VYNE Pharmaceuticals Inc. Executive Employment Offer Letter with Tyler Zeronda (Interim CFO)
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NJ
2021
Controlled Equity Offering Sales Agreement between VYNE Therapeutics Inc. and Cantor Fitzgerald & Co. (August 12, 2021)
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021
VYNE Pharmaceuticals Inc. Offer Letter of Employment for Chief Financial Officer (Andrew)
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2021
VYNE Pharmaceuticals Inc. Offer Letter to Mutya for Chief Legal Officer Position
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2021
Description of Registered Securities of VYNE Therapeutics Inc. under Section 12 of the Exchange Act
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2021
VYNE Therapeutics Inc. 2018 Omnibus Incentive Plan Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2021
Securities Purchase Agreement between VYNE Therapeutics Inc. and Purchasers dated January 26, 2021
Purchase Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021
License Agreement between Foamix Pharmaceuticals Ltd. and Cutia Therapeutics (HK) Limited Dated April 21, 2020
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Amendment No. 1 to Amended and Restated Credit Agreement and Guaranty among Foamix Pharmaceuticals Inc., Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc., and Perceptive...
Credit Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Menlo Therapeutics Inc. Underwriting Agreement for Common Stock Offering with Cowen and Piper Sandler (June 2020)
Underwriting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Second Amended and Restated Warrant Certificate between Menlo Therapeutics Inc. and Perceptive Credit Holdings II, LP
Warrant Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2020
Second Amended and Restated Warrant Certificate between Menlo Therapeutics Inc. and Orbimed Royalty & Credit Opportunities III, LP
Warrant Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2020
Amended and Restated Credit Agreement and Guaranty among Foamix Pharmaceuticals Inc., Menlo Therapeutics Inc., Subsidiary Guarantors, Lenders, and Perceptive Credit Holdings II,...
Credit Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Amended and Restated Security Agreement among Foamix Pharmaceuticals Inc., Menlo Therapeutics Inc., Subsidiaries, and Perceptive Credit Holdings II, LP
Security Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Menlo Therapeutics Inc. 2019 Equity Incentive Plan
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2020
Menlo Therapeutics Inc. Share Option Grant Notice and Option Agreement (2019 Equity Incentive Plan)
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Menlo Therapeutics Inc. Restricted Share Unit Grant Notice and Award Agreement (2019 Equity Incentive Plan)
Compensation Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Menlo Therapeutics Inc. Share Option Grant Notice and Option Agreement (2019 Equity Incentive Plan)
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Menlo Therapeutics Inc. Restricted Share Unit Grant Notice and Award Agreement (2019 Equity Incentive Plan)
Compensation Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Menlo Therapeutics Inc. 2019 Employee Share Purchase Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Employment Agreement between Foamix Pharmaceuticals Inc. and David Domzalski (CEO) Effective March 9, 2020
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NJ
2020
Menlo Therapeutics Inc. Chief Financial Officer Employment Offer Letter to Andrew (March 2020)
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NJ
2020
Termination of Employment and Release Agreement between Foamix Pharmaceuticals Ltd. and Ilan Hadar
Separation Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Amended and Restated Warrant Certificate between Menlo Therapeutics Inc. and Initial Holder (March 2020)
Warrant Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2020
Contingent Stock Rights Agreement between Menlo Therapeutics Inc. and American Stock Transfer & Trust Company, LLC (March 9, 2020)
Stock Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Description of Menlo Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Menlo Voting Agreement between Foamix Pharmaceuticals Ltd. and Stockholder (2019)
Voting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
Foamix Voting Agreement between Menlo Therapeutics Inc. and Stockholder (2019)
Voting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
Contingent Stock Rights Agreement between Menlo Therapeutics Inc. and Rights Agent (Foamix Merger)
Warrant Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
Professional Services Agreement between Menlo Therapeutics Inc. and Mary Spellman, M.D.
Services Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2019
Menlo Therapeutics Inc. Employment Offer Letter to Mary for Senior Vice President, Clinical Development
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Amendment No. 1 to Offer Letter between Menlo Therapeutics Inc. and Mary Spellman
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Amendment No. 1 to Offer Letter between Menlo Therapeutics Inc. and Steven Basta
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Exclusive License Agreement between Merck Sharp & Dohme Corp. and Tigercat Pharma, Inc.
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2018
License and Collaboration Agreement between Menlo Therapeutics Inc., Torii Pharmaceutical Co., Ltd., and Japan Tobacco Inc. (Serlopitant in Japan)
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2018
Underwriting Agreement between Menlo Therapeutics Inc. and Jefferies LLC, Piper Jaffray & Co, and Guggenheim Securities LLC (2018)
Underwriting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2018
Stock Certificate Transfer and Rights Statement for Shareholders
Stock Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Menlo Therapeutics Inc. 2018 Employee Stock Purchase Plan
Stock Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2018
Menlo Therapeutics Inc. 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2018
Menlo Therapeutics Inc. 2018 Omnibus Incentive Plan Stock Option Award Agreement with Grantee
Equity Distribution Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2018
Second Amended and Restated Investors’ Rights Agreement between Menlo Therapeutics Inc. and Investors (June 28, 2017)
Investor Rights Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2017
Exclusive License Agreement between Merck Sharp & Dohme Corp. and Tigercat Pharma, Inc.
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2017
License and Collaboration Agreement between Menlo Therapeutics Inc., Torii Pharmaceutical Co., Ltd., and Japan Tobacco Inc. (August 10, 2016)
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Tigercat Pharma, Inc. Employment Agreement with Steven L. Basta as President and CEO
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2017
Tigercat Pharma, Inc. Chief Medical Officer Employment Offer Letter to Paul Kwon, MD
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2017
Menlo Therapeutics Inc. Employment Offer Letter to Kristine Ball for CFO and SVP Corporate Strategy
Employment Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2017
Consulting Agreement between Tigercat Pharma, Inc. and David Collier
Consulting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2017
Indemnification Agreement between Menlo Therapeutics Inc. and Director/Officer
Indemnification Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Indemnification Agreement between Menlo Therapeutics Inc. and Indemnitee
Indemnification Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Tigercat Pharma, Inc. 2011 Stock Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Amendment to Tigercat Pharma, Inc. 2011 Stock Incentive Plan (Effective February 13, 2017)
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2017
Tigercat Pharma, Inc. 2011 Stock Incentive Plan Stock Option Award Agreement with Participant
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2017
Tigercat Pharma, Inc. 2011 Stock Incentive Plan Notice of Stock Option Award and Award Agreement
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2017
Amendment No. 1 to Agreement and Plan of Merger among Menlo Therapeutics Inc., Giants Merger Subsidiary Ltd., and Foamix Pharmaceuticals Ltd.
Merger Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2019
Amendment No. 1 to Agreement and Plan of Merger among Menlo Therapeutics, Giants Merger Subsidiary, and Foamix Pharmaceuticals
Merger Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2019
Agreement and Plan of Merger among Menlo Therapeutics Inc., Giants Merger Subsidiary Ltd., and Foamix Pharmaceuticals Ltd.
Merger Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
First Amendment to Sublease Agreement between Relypsa, Inc. and Menlo Therapeutics, Inc. dated April 12, 2019
Lease Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2019
Amendment No. 1 to Offer Letter between Menlo Therapeutics Inc. and Kristine Ball
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Amendment No. 1 to Offer Letter between Menlo Therapeutics Inc. and Paul Kwon
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Sublease Agreement between Relypsa, Inc. and Menlo Therapeutics, Inc. for 200 Cardinal Way, Redwood City, CA
Lease Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2017